IOVA SHAREHOLDERS: The Iovance Biotherapeutics July 14 Class Action Deadline is Approaching — Contact BFA Law if You Suffered Losses (NASDAQ:IOVA)
(NasdaqGM:IOVA), NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to […]